ALMDT Median Technologies

Median Technologies is Awarded the Futur40 Prize, an Initiative Launched by Forbes France

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--

Regulatory News:

Median Technologies (Paris:ALMDT), the Imaging Phenomics Company™, announces that on July 13th 2017, it was awarded the Futur40 Prize by Forbes France, in association with PME finance - Europe Entrepreneurs, the French Finance Association Paris Europlace and the Federation of Individual Investors and the Finance Clubs (F2iC – Fédération des Investisseurs Individuels et des Clubs d’investissement).

The Futur40 ranking is based on data provided by Morningstar and highlights the 40 Paris-listed companies that have distinguished themselves based on their financial performance and the originality of their model.

The criteria for obtaining the Futur40 award are as follows:

  • Cumulative sales growth of more than 15% over the last three years,
  • € 5 million of minimum turnover, and
  • The company listed in Paris with a minimum stock footprint (free float, trading volume) to have certified public data.

About Median Technologies: Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. We leverage the power of Imaging Phenomics™ to provide insights into novel therapies and treatment strategies. Our unique solutions, LMS for lesion management and iBiopsy® for imaging phenotyping, together with our global team of experts, are advancing the development of new drugs and diagnostic tools to monitor disease and assess response to therapy. Median Technologies supports biopharmaceutical sponsors and healthcare professionals around the world to quickly and precisely bring new treatments to patients in need, with an eye on reducing overall care costs. This is how we are helping to create a healthier world.

Founded in 2002, based in Sophia-Antipolis, France, with a US subsidiary in Boston, Median has received the label “Innovative company” by the BPI and is listed on Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). The company is eligible for the PEA-PME SME equity savings plan setup and has received the label Pass French Tech Promotion 2016-2017. Median Technologies has been awarded the 2017 Tech 40 Label and has joined the EnterNext Tech 40 Index. Median is a member of the Bpifrance Excellence Network. More information: www.mediantechnologies.com

EN
18/07/2017

Underlying

ALMDTMedian Technologies

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Median Technologies

Free Trial
ALMDT Median Technolo...

Median Technologies: 1 director

A director at Median Technologies bought 56,242 shares at 1.660EUR and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...

ALMDT MEDIAN TECHNOLOGIES
08/15/25 August 15, 2025 1 EN
Maria Vara
  • Maria Vara
ALMDT Median Technolo...

Median Technologies: EUR23.5m capital raise extends runway into Q4 202...

Median Technologies successfully secured a capital raise via ABSA of EUR23.5m in total gross proceeds, priced at EUR1.66 (at ~18% discount to 20-day VWAP). The offering was oversubscribed, surpassing the initial EUR22m target, with 64% backed by existing shareholders, 2% by a public offering in Fra

ALMDT MEDIAN TECHNOLOGIES
08/04/25 August 4, 2025 1 EN
Maria Vara
  • Maria Vara
ALMDT Median Technolo...

Median Technologies: Launch of EUR22m capital increase to unlock EIB f...

Median Technologies has launched a EUR22m capital increase via a public offering of shares with warrants (ABSA), priced at EUR1.66 (at ~18% discount to 20-day VWAP), with 78% of the deal already secured via existing and new investors. The raise aimed to i) meet the drawing conditions of the Tranche

ALMDT MEDIAN TECHNOLOGIES
07/22/25 July 22, 2025 1 EN
Maria Vara
  • Maria Vara
ALMDT Median Technolo...

Median Technologies: EIB loan signed, tied to equity raise and debt re...

Friday post-market, Median announced the final sign of the EIB loan agreement of EUR37.5m, which has been structured in three tranches (EUR19m, EUR8.5m, EUR10m) and with several key conditions being set to access the first one. These include i) a capital increase of at least EUR16m (including issua

ALMDT MEDIAN TECHNOLOGIES
07/14/25 July 14, 2025 1 EN
Maria Vara
  • Maria Vara
ALMDT Median Technolo...

Median Technologies: CE mark filing keep eyonis on track, US launch be...

Yesterday post-market, Median announced that it has submitted the Class IIb CE marking filing for eyonis LCS, just a month after the FDA 510(k) submission, precisely sticking to the company's timeline guidance. Our confidence in a positive outcome remains high, as both submissions are underpinned b

ALMDT MEDIAN TECHNOLOGIES
07/02/25 July 2, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch